AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 189 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $114,200 | +14.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $100,200 | -44.3% | 20,000 | 0.0% | 0.00% | -33.3% |
| Q4 2023 | $179,800 | +15.7% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $155,400 | -19.7% | 20,000 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $193,600 | -41.1% | 20,000 | -33.3% | 0.00% | -42.9% |
| Q1 2023 | $328,800 | +280.6% | 30,000 | +50.0% | 0.01% | +250.0% |
| Q4 2022 | $86,400 | -42.4% | 20,000 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $150,000 | -25.4% | 20,000 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $201,000 | -19.0% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $248,000 | -45.7% | 20,000 | 0.0% | 0.01% | -50.0% |
| Q4 2021 | $457,000 | +3.2% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $443,000 | +581.5% | 20,000 | +300.0% | 0.01% | +400.0% |
| Q2 2021 | $65,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 188,500 | $4,311,000 | 3.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 334,500 | $7,647,000 | 1.70% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 131,760 | $3,013,000 | 1.49% |
| NEA Management Company, LLC | 3,069,834 | $70,207,000 | 1.42% |
| Berry Street Capital Management LLP | 575,000 | $13,151,000 | 1.36% |
| Melqart Asset Management (UK) Ltd | 916,321 | $20,956,000 | 1.06% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $2,287,000 | 0.93% |
| HighMark Wealth Management LLC | 50,499 | $1,155,000 | 0.73% |
| Artal Group S.A. | 1,000,000 | $22,870,000 | 0.62% |
| Vigilare Wealth Management | 34,925 | $799,000 | 0.47% |